PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$34.56
+0.33%Forward multiples
Based on analyst estimates
- P/E forward
- 9.86x
- P/E 2026E
- 11.33x
- P/E 2027E
- 9.94x
- P/E 2028E
- 9.04x
- P/S forward
- 0.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.05x
- PEG TTM
- 0.33x
- Price / book
- 3.64x
- Price / sales
- 0.92x
- Price / cash flow
- 20.35x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 1.39x
- EV / EBITDA
- 8.92x
- EV / EBIT
- 10.63x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026